1,300 more officials for US FDA

4 May 2008

The US Food and Drug Administration has announced details of a major hiring initiative to fill 1,300 positions within the next few months. John Dyer, the agency's Deputy Commissioner for Operations, said: "it takes a large pool of talented people for the FDA to protect and promote the public health."

For the 2008 fiscal year, the FDA intends to fill more than 700 vacant posts and an additional 600 new positions. The combined total would triple the hiring levels of 2005-2007 and come as a result of funding provisions laid out in the Food and Drug Administration Amendments Act of 2007 (Marketletters passim) and the Import Safety Plan. Other legislative and administrative measures affecting food safety account for some of the funding.

A fast-track recruitment policy has been agreed with the Department Health and Human Services (which has responsibility for the FDA) Office of Personnel Management, so that some qualified candidates could be in place within three weeks, the agency noted. The timing of the FDA's move is a boost for medical and scientific graduates and coincides with fears of a recession and restructuring by several leading US pharmaceutical companies (Marketletters passim).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight